Endocrine toxicity is an independent predictor of survival in lung cancer patients treated with immune checkpoint inhibitors

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Patient with immune checkpoint inhibitor Pembrolizumab associated endocrine dysfunctions: a report of clinical case2024
2. 2Combined endocrine-related adverse effects of immune checkpoint inhibitors in a male patient with advanced cutaneous melanoma and multiple co-morbidities2024
3. 3Endocrine autoimmunity during immunotherapy for cancer - a snapshot from an Oncologic Institute in Romania2024
4. 4Adrenocortical carcinoma revealed by pulmonary embolism2024
5. 5Bone disorders in oncological patients treated with Immune-Checkpoint Inhibitors (ICIs)2024